Showing results (571-580 of 687) with videos related to

Sort By:
Pageof 69
Oncogene|April 18, 2017
Autophagy supports generation of cells with high CD44 expression via modulation of oxidative stress and Parkin-mediated mitochondrial clearanceK A Whelan, P M Chandramouleeswaran, K Tanaka, et al.
Cancer Cell|January 24, 2012
Bile acid and inflammation activate gastric cardia stem cells in a mouse model of Barrett-like metaplasiaMichael Quante, Govind Bhagat, Julian A Abrams, et al.
Therapeutic Advances in Gastroenterology|September 2, 2015
The impact of an educational program on HCV patient outcomes using boceprevir in community practices (OPTIMAL trial)Fred Poordad, Vinod Rustgi, Robert S Brown, et al.
Cancer Research|October 3, 2007
Cell cycle dependent and schedule-dependent antitumor effects of sorafenib combined with radiationJohn P Plastaras, Seok-Hyun Kim, Yingqiu Y Liu, et al.
Cancer Research|April 29, 2010
Epidermal growth factor receptor and mutant p53 expand an esophageal cellular subpopulation capable of epithelial-to-mesenchymal transition through ZEB transcription factorsShinya Ohashi, Mitsuteru Natsuizaka, Gabrielle S Wong, et al.
Annals of Hepatology|December 15, 2011
Balapiravir plus peginterferon alfa-2a (40KD)/ribavirin in a randomized trial of hepatitis C genotype 1 patientsDavid R Nelson, Stefan Zeuzem, Pietro Andreone, et al.
The New England Journal of Medicine|January 20, 2012
Preliminary study of two antiviral agents for hepatitis C genotype 1Anna S Lok, David F Gardiner, Eric Lawitz, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 28, 2012
Structural genes of wheat and barley 5-methylcytosine DNA glycosylases and their potential applications for human healthShanshan Wen, Nuan Wen, Jinsong Pang, et al.
Alimentary Pharmacology & Therapeutics|January 29, 2015
Virological outcomes and treatment algorithms utilisation in observational study of patients with chronic hepatitis C treated with boceprevir or telaprevirR K Sterling, A Kuo, V K Rustgi, et al.
Cancer Research|August 5, 2016
JARID1B Enables Transit between Distinct States of the Stem-like Cell Population in Oral CancersNicole D Facompre, Kayla M Harmeyer, Xavier Sole, et al.
Pageof 69